# Rosiglitazone Effects on Cognition for Adults in Later Life

> **NCT00242593** · PHASE2 · UNKNOWN · sponsor: **University of Washington** · enrollment: 120 (estimated)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00242593
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-08-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242593, "Rosiglitazone Effects on Cognition for Adults in Later Life". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00242593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*